Cart
sales@molnova.com
Pyrabactin
CAS No. 419538-69-5
Pyrabactin( —— )
Catalog No. M24382 CAS No. 419538-69-5
Pyrabactin is a seed-selective abscisic acid (ABA) agonist, Novel PYL agonist; acting as a plant growth inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 123 | In Stock |
|
| 10MG | 176 | In Stock |
|
| 25MG | 302 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePyrabactin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPyrabactin is a seed-selective abscisic acid (ABA) agonist, Novel PYL agonist; acting as a plant growth inhibitor.
-
DescriptionPyrabactin is a seed-selective abscisic acid (ABA) agonist, Novel PYL agonist; acting as a plant growth inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPYR/PYL/RCARs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number419538-69-5
-
Formula Weight377.26
-
Molecular FormulaC16H13BrN2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10mg/mL (26.50 mM)
-
SMILESO=S(c(c1ccccc11)ccc1Br)(NCc1ncccc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.González-Villagra J, et al. Evaluating the involvement and interaction of abscisic acid and miRNA156 in the induction of anthocyanin biosynthesis in drought-stressed plants. Planta. 2017 May 22.
molnova catalog
related products
-
21-O-Tigloylgymnemag...
21-O-Tigloylgymnemagenin is a natural product.
-
Odonicin
Odonicin is a kind of natural product derived from the herbs of Rabdosia longituba.
-
Syk Inhibitor II hyd...
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.
